mci 9038 has been researched along with Angina at Rest in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buerke, M; Desaga, M; Genth-Zotz, S; Gulba, DC; Harder, S; Heyndrickx, GR; Rau, M; Rössig, L; Schneider, T; Zeiher, AM | 1 |
| Butterworth, J; Cannon, MA; Hyland, JM; Riley, RD | 1 |
| Lepor, NE | 1 |
| Bovill, EG; Collen, D; Garabedian, HD; Gold, HK; Hagstrom, JN; Newell, JB | 1 |
| Garabedian, HD; Gold, HK; Hagstrom, JN; Jang, IK; Khan, A; Leinbach, RC; Newell, JB; Torres, FW; Werner, W; Yasuda, T | 1 |
| Casscells, W; Willerson, JT | 1 |
| Berry, CN; Duval, N; Grosset, A; Lunven, C; O'Brien, DP; O'Connor, SE | 1 |
| Théroux, P; Xiao, Z | 1 |
| Armstrong, PW; Choy, JB | 1 |
| Cella, G; Girolami, A; Sasahara, AA | 1 |
| White, HD; Wong, CK | 1 |
| Fleischer, K; Gulba, DC; Lankes, W | 1 |
5 review(s) available for mci 9038 and Angina at Rest
| Article | Year |
|---|---|
Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Fondaparinux; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Models, Molecular; Molecular Structure; Myocardial Ischemia; Peptide Fragments; Pipecolic Acids; Platelet Activation; Polysaccharides; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thrombosis | 2007 |
Anticoagulant therapy in unstable angina.
Topics: Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Clinical Trials as Topic; Coronary Thrombosis; Disease Progression; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Warfarin | 1999 |
Medical treatment for acute coronary syndromes.
Topics: Angina, Unstable; Arginine; Coronary Angiography; Fibrinolytic Agents; Heparin; Humans; Metalloendopeptidases; Myocardial Infarction; Pipecolic Acids; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sulfonamides; Survival Rate; Syndrome; Thrombolytic Therapy; Tissue Plasminogen Activator | 2000 |
[Direct thrombin antagonists].
Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Antithrombins; Arginine; Azetidines; Benzylamines; Fibrinolytic Agents; Glycine; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Rabbits; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Time Factors | 2001 |
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
Topics: Angina, Unstable; Antithrombins; Arginine; Glycine; Heparin; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Oligopeptides; Peptide Fragments; Pipecolic Acids; Piperidines; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Survival Rate; Thrombin | 2002 |
3 trial(s) available for mci 9038 and Angina at Rest
| Article | Year |
|---|---|
Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Blood Coagulation; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombosis | 2011 |
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Topics: Aged; Angina, Unstable; Antithrombin III; Antithrombins; Arginine; Blood Coagulation; Drug Administration Schedule; Female; Fibrinopeptide A; Humans; Infusions, Intravenous; Male; Middle Aged; Pipecolic Acids; Recurrence; Sulfonamides; Thrombin; Treatment Outcome | 1993 |
Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Dose-Response Relationship, Drug; Enoxaparin; Female; Heparin; Humans; Male; Middle Aged; P-Selectin; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Platelet Activation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides | 1998 |
5 other study(ies) available for mci 9038 and Angina at Rest
| Article | Year |
|---|---|
Failure of argatroban anticoagulation during off-pump coronary artery bypass surgery.
Topics: Aged; Angina, Unstable; Antibodies; Anticoagulants; Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Restenosis; Dose-Response Relationship, Drug; Graft Occlusion, Vascular; Heparin; Humans; Male; Myocardial Revascularization; Partial Thromboplastin Time; Pipecolic Acids; Reoperation; Stents; Sulfonamides; Treatment Failure | 2004 |
Accelerated thrombin generation during anticoagulation in patients with unstable angina pectoris.
Topics: Angina, Unstable; Antithrombin III; Antithrombins; Arginine; Humans; Infusions, Intravenous; Peptide Hydrolases; Pipecolic Acids; Sulfonamides; Thrombin; Time Factors | 1994 |
Thrombin inhibitors in unstable angina: rebound or continuation of angina after argatroban withdrawal?
Topics: Angina, Unstable; Antithrombin III; Antithrombins; Arginine; Humans; Pipecolic Acids; Recurrence; Sulfonamides; Thrombin | 1993 |
Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.
Topics: Angina, Unstable; Animals; Antithrombins; Arginine; Coronary Vessels; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Heparin; Male; Pipecolic Acids; Sulfonamides; Thrombin Time; Time Factors | 1996 |
Platelet activation with unfractionated heparin at therapeutic concentrations and comparison with low-molecular-weight heparin and with a direct thrombin inhibitor.
Topics: Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Platelet Activation; Platelet Aggregation Inhibitors; Sulfonamides; Thrombolytic Therapy | 1999 |